Ovarian Cancer pp 185-208 | Cite as

Cytopathology of the Ovary

  • D. V. S. DeFrias
  • A. M. Okonkwo
  • P. C. Keh
  • R. Nayar
Part of the Cancer Treatment and Research book series (CTAR, volume 107)


The ovaries are pelvic organs located bilaterally and attached to the uterine cornua and fallopian tubes by several ligaments that maintain their lateral location. There are various components of a normal ovary that are important to recognize. Many of these components undergo cyclical changes secondary to hormonal manifestations.


Granulosa Cell Germ Cell Tumor Embryonal Carcinoma Dermoid Cyst Ovarian Surface Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arey, L.B., The origin and form of the Brenner tumor. Am J Obstet Gynecol, 1961; 81: 74351.Google Scholar
  2. Beckstead, J.H., Alkaline phosphatase histochemistry in human germ cell neoplasia. Am J Surg Pathol, 1983; 7: 341–349.PubMedCrossRefGoogle Scholar
  3. Bell, D.A. and R.E. Scully, Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases. Am J Surg Pathol, 1985; 9: 205–14.PubMedCrossRefGoogle Scholar
  4. Berchuck, A., et al., Managing hereditary ovarian cancer risk. [Review]. Cancer 1999; 86 (11): 2517–24.PubMedCrossRefGoogle Scholar
  5. Castilla, L.H., F.J. Couch, and M.R.e.a. Erdos, Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 1994; 2: 128–131.Google Scholar
  6. Clement, P.B., Blaustein’s pathology of the female genital tract. 4th edition ed. NY: Springer-Verlag, 1996.Google Scholar
  7. Commerci, J.T., et al., mature cystic teratoma: a clinocpathologic evaluation of 517 cases and review of the literature. Obstet Gynecol, 1994; 84: 22–28Google Scholar
  8. DePriest, P.D., E.R. Banks, and D.E.e.a. Powell, Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol, 1992; 47: 71–5.PubMedCrossRefGoogle Scholar
  9. Easton, D.F., D. Ford, and D.T. Bishop, Breast cancer linkage consortium. Breast and ovarian cancer incidence in BRCA-1 mutation carriers. Am J Hum Genet., 1995; 56: 265–271.PubMedCrossRefGoogle Scholar
  10. Erlich, C.E. and L. Roth, The Brenner tumor. A clinicopathologic study of 57 cases. Cancer, 1971; 27: 332–42.CrossRefGoogle Scholar
  11. Ford, D., et al., Breast cancer linkage consortium. Risk of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692–695.PubMedCrossRefGoogle Scholar
  12. Frank, T.S. and A.M. Braverman, The pros and cons of genetic testing for breast and ovarian cancer risk (review). International Journal of Fertility and Reproductive Medicine 1999; 44 (3): 139–45.Google Scholar
  13. Fukunnaga, M., et al., Ovarian atypical endometriosis: its close association with malignant epithelial tumors. Histopathology, 1997; 30: 249–55.CrossRefGoogle Scholar
  14. Futreal, P.A., Q.Y. Liu, and D.E.A. Shattuck-Eldens, BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120–122.PubMedCrossRefGoogle Scholar
  15. Gompel, E. and S.G. Silverberg, Chapter 6, in Pathology in Gyneclogy and Obstetrics. J.B. Lippincott Company, 1994.Google Scholar
  16. Hall, J.M., M.K. Lee, and B.e.a. Newman, Linkage of early-onset familial breast cancer to chromosome 17g21. Science 1992: 1684–1689.Google Scholar
  17. Hart, W.R. and H.J. Norris, Borderline and malignant mucinous tumors of the ovary. Histologic riteria and clinical behavior. Cancer, 1973; 31 (5): 1031–45.PubMedCrossRefGoogle Scholar
  18. Hendrickson, M.R., Surface epithelial neoplasms of the ovary, in State of the Art Reviews. Pathology. Hanley and Belfus: Philadelphia, 1992.Google Scholar
  19. Katsube, Y., J.W. Berg, and S.G. Silverberg, Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver standard metropolital statistical area, 1 July–31 December 1969 and 1 July 31 December 1979. Int J Gynecol Pathol, 1982; 1: 3–16.PubMedCrossRefGoogle Scholar
  20. Kline RC et al., Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol, 1990; 39: 337–46.PubMedCrossRefGoogle Scholar
  21. Koonings, P.P., et al., Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet Gynecol, 1989; 74: 921–926.PubMedGoogle Scholar
  22. Kurman, R.J. and H.J. Norris, Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol, 1976; 48: 579–589.PubMedGoogle Scholar
  23. Kurman, R.J. and H.J. Norris, Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer, 1976; 38: 2420–2433.PubMedCrossRefGoogle Scholar
  24. Lee, W.Y., et al., Immuno-localization of BRCA1 protein in normal breast tissue and sporadic breast invasive ductal carcinomas: a correlation with other biological parameters. Histopathology, 1999; 34: 106–112.PubMedCrossRefGoogle Scholar
  25. Mostoufizadeh, M. and R.E. Sculley, Malignant tumors arising in endometriosis. Clin Obstet Gynecol, 1980; 23: 951–63.PubMedGoogle Scholar
  26. McKay D.G., et al., The adult human ovary, a histochemical study. Obstet and Gynecol, 1961; 18: 13–39.Google Scholar
  27. Nogales, F.F., et al., Immature teratoma of the ovary with neural component (solid teratoma): A clinicopathologic study of 20 cases. Hum Pathol, 1976; 7: 625–642.PubMedCrossRefGoogle Scholar
  28. O’Connor, D.M. and H.J. Norris, The influence of grade on the outcome of stage 1 ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol, 1994;Google Scholar
  29. Oliva, E., et al., Ovarian carcinomas with choriocarcinomatous differentiation. Cancer, 1993; 72: 2441–2446.PubMedCrossRefGoogle Scholar
  30. Peterson, F. Annual report of treatment in gynecological cancer. in International Federation of Gynecology and Obstetrics.Stockholm, 1999.Google Scholar
  31. Scully, E.R., R.H. Young, and P.B. Clement, Tumors of the ovary, maldeveloped gonads, fallopian tubes and broad ligament. third series ed. Atlas of tumor pathology. Vol. 23. 1998: AFIP.Google Scholar
  32. Shih, I. and R. Kurman, Immunohistochemical localization of inhibin alpha in the placenta and gestational trophoblastic lesions. Intl J of Gyecol path, 1999; 18 (2): 144–150.CrossRefGoogle Scholar
  33. Simard, L., Polyembryonic embryoma of the ovary of pathogenic origin. Cancer, 1957; 10: 215–223.PubMedCrossRefGoogle Scholar
  34. Reagan, JW., Ceroid pigment in the human ovary. Am. J Obstet Gynecol, 1950; 59: 433–436. Ruffner, H. and I.M. Verma, BRCAI is a cell cycle-regulated nuclear phosphoprotein. Natl Acad Sci. 1997; 94: 7138–7143.Google Scholar
  35. Russell, P. and A. Farnsworth, Surgical pathology of the ovaries. second edition ed. United kingdom: Churchhill Livingstone, 1997.Google Scholar
  36. Russell, P., Blaustein’s pathology of the female genital tract. 4th edition ed. NY: Springer-Verlag, 1996.Google Scholar
  37. Russell, P., The pathological assessment of ovarian neoplasms: I: Introduction to the common ‘epithelial’ tumors and analysis of benign ‘epithelial’ tumors. Pathology, 1979. 11: 493–532.Google Scholar
  38. Sasaki, H., M. Furusato, and S.e.a. Teshima, Prognostic significance of histopathologic subtypes in stage I pure yolk sac tumor of the ovary. British J Cancer, 1994; 69: 529–536.CrossRefGoogle Scholar
  39. Shen, D. and J.V. Vadgama, BRCA1 amd BRCA2 gene mutation analysis: visit to the breast cancer information core (BIC). Oncology Research, 1997; 11 (2): 63–9.Google Scholar
  40. Smith, T.E., Meeting to sort out BRCA1 confusion. Science 1996. 272: p. 799.CrossRefGoogle Scholar
  41. Snyder, R.R., H.J. Norris, and F. Tavassoli, Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases. Am J Surg Pathol, 1988; 12: 661–71.PubMedCrossRefGoogle Scholar
  42. Telium, G., Endodermal sinus tumors of the ovary and testis. comparative morphogenesis of the so-called mesonephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of rat placenta. Cancer, 1959; 12: 1092–1105.CrossRefGoogle Scholar
  43. Wang, H., et al., BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCAIa, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 1997; 15: 143–157.PubMedCrossRefGoogle Scholar
  44. Wojcik, E.M. and B. Naylor, “Collagen balls” in peritoneal washings. Acta cytologica, 1992; 46: 466–470.Google Scholar
  45. Zaloudek, C.J., F.A. Tavassoli, and H.J. Norris, Dysgerminoma with syncytiotrophoblastic cells. A histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol, 1981; 5: 361–367.PubMedCrossRefGoogle Scholar
  46. Zhang, H.T., X. Zhang, and H.Z.e.a. Zhao, Relationship of p215BRCAI to tyrosine kinase signaling pathways and the and the cell cycle in normal and transfomed cells. Oncogene 1997; 14: 2863–2869.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • D. V. S. DeFrias
    • 1
  • A. M. Okonkwo
    • 1
  • P. C. Keh
    • 1
  • R. Nayar
    • 1
  1. 1.Department of PathologyNorthwestern University Medical SchoolChicagoUSA

Personalised recommendations